Literature DB >> 30959413

Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment.

Bun Yamagata1, Kaori Yamanaka2, Yuichi Takei3, Shogo Hotta2, Jinichi Hirano2, Hajime Tabuchi2, Masaru Mimura2.   

Abstract

BACKGROUND: Major depressive disorder (MDD) is a heterogeneous condition. Identifying the brain responses to antidepressant treatment is of particular interest as these may represent potential neural networks related to treatment response, forming one aspect of the biological markers of MDD. Near-infrared spectroscopy (NIRS) is suitable for repeated measurements with short intervals because of its noninvasiveness, and can provide detailed time courses of functional alterations in prefrontal regions.
METHODS: We conducted a 12-week longitudinal study to explore prefrontal hemodynamic changes at 4-week intervals following sertraline treatment in 11 medication-naïve participants with MDD using 52-channel NIRS.
RESULTS: While all participants achieved remission after treatment, intra-class correlation coefficient of oxygenated hemoglobin [oxy-Hb] values throughout the 12-week observation was moderate at the spatially and temporally contiguous cluster located in the left inferior frontal and temporal gyri. There was a significant negative correlation between mean [oxy-Hb] values in the significant cluster at 4 weeks and changes in Hamilton Rating Scale for Depression total score from 4 to 8 weeks (r = -0.73, P = 0.011) and from 4 to 12 weeks (r = -0.63, P = 0.039). LIMITATIONS: Without healthy controls for comparison, we were unable to fully evaluate whether improvement of [oxy-Hb] activations after treatment in MDD reached normal levels or not.
CONCLUSION: Our NIRS findings of detailed prefrontal hemodynamic alterations over short interval observations such as 4 weeks may have revealed potential trait marker for MDD and biological maker for predicting clinical response to sertraline treatment in MDD.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Antidepressant treatment; Depression; Longitudinal study; Near-infrared spectroscopy; Neuroimaging; Sertraline

Year:  2019        PMID: 30959413     DOI: 10.1016/j.jad.2019.04.001

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  rTMS Therapy Reduces Hypofrontality in Patients With Depression as Measured by fNIRS.

Authors:  Yasuo Kawabata; Shin-Ichi Imazu; Koichi Matsumoto; Katsunori Toyoda; Makoto Kawano; Yoichiro Kubo; Shinya Kinoshita; Yoshitaka Nishizawa; Tetsufumi Kanazawa
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

2.  Diagnostic and Predictive Applications of Functional Near-Infrared Spectroscopy for Major Depressive Disorder: A Systematic Review.

Authors:  Cyrus S H Ho; Lucas J H Lim; A Q Lim; Nicole H C Chan; R S Tan; S H Lee; Roger C M Ho
Journal:  Front Psychiatry       Date:  2020-05-06       Impact factor: 4.157

3.  Promising Neuroimaging Biomarkers in Depression.

Authors:  Chien-Han Lai
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

Review 4.  Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder.

Authors:  Seung-Gul Kang; Seo-Eun Cho
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.